You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Somerset Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SOMERSET, and what generic and branded alternatives to SOMERSET drugs are available?

SOMERSET has thirty-five approved drugs.

Summary for Somerset

US Patents:	0
Tradenames:	31
Ingredients:	28
NDAs:	35

Drugs and US Patents for Somerset

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Somerset Theraps Llc	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	210882-001	Aug 17, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset Theraps Llc	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	206503-001	Dec 11, 2015	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset	SUMATRIPTAN SUCCINATE	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	213998-001	Jul 13, 2021	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset Theraps Llc	OLOPATADINE HYDROCHLORIDE	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	206306-001	Dec 7, 2015		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset Theraps Llc	BIMATOPROST	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	207601-001	Jun 19, 2019	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset	CALCIUM GLUCONATE	calcium gluconate	SOLUTION;INTRAVENOUS	217689-002	Oct 19, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Somerset	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	207521-001	Jun 8, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Somerset

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006	7,070,808	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	7,638,140	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	7,638,140	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	RE34579	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	7,070,808	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	RE34579	⤷ Try a Trial
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	7,150,881	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.